Publications

Emerging Infectious Diseases (EID)

Back to Top

Other References
  • Mas-Coma S, Bargues MD, Valero MA. Human fascioliasis infection sources, their diversity, incidence factors, analytical methods and prevention measuresExternal. Parasitol 2018;145(13):1665–99.
  • Dolay K, Hasbahçeci M, Hatipoğlu E, Ümit Malya F, Akçakaya A. Endoscopic diagnosis and treatment of biliary obstruction due to acute cholangitis and acute pancreatitis secondary to Fasciola hepatica infection. Ulus Travma Acil Cerrahi Derg 2018;24:71–3.
  • Cabada MM, Lopez M, Cruz M, Delgado JR, Hill V, White AC, Jr. Treatment failure after multiple courses of triclabendazole among patients with fascioliasis in Cusco, Peru: a case series. PLoS Negl Trop Dis 2016;10:e0004361.
  • Boşnak VK, Karaoğlan I, Sahin HH, Namiduru M, Pehlivan M, Okan V, Mete AO. Evaluation of patients diagnosed with fascioliasis: a six-year experience at a university hospital in Turkey. J Infect Dev Ctries 2016;10:389–94.
  • Machicado C, Machicado JD, Maco V, Terashima A, Marcos LA. Association of Fasciola hepatica infection with liver fibrosis, cirrhosis, and cancer: a systematic review. PLoS Negl Trop Dis 2016;10:e0004962.
  • Maco V, Marcos L, Delgado J, Herrera J, Nestares J, Terashima A, Samalvides F, Gotuzzo E. Efficacy and tolerability of two single-day regimens of triclabendazole for fascioliasis in Peruvian children. Rev Soc Bras Med Trop 2015;48:445–53.
  • Lukambagire AH, Mchaile DN, Nyindo M. Diagnosis of human fascioliasis in Arusha region, northern Tanzania by microscopy and clinical manifestations in patients. BMC Infect Dis 2015;15:578.
  • Ashrafi K, Bargues MD, O’Neill S, Mas-Coma S. Fascioliasis: a worldwide parasitic disease of importance in travel medicine. Travel Med Infect Dis 2014;12(6 Pt A):636–49.
  • Mas-Coma S, Valero MA, Bargues MD. Fascioliasis. Adv Exp Med Biol 2014;766:77–114.
  • Mas-Coma S, Agramunt VH, Valero MA. Neurological and ocular fascioliasis in humans. Adv Parasitol 2014;84:27–149.
  • Weisenberg SA, Perlada DE. Case report: domestically acquired fascioliasis in northern California. Am J Trop Med Hyg 2013;89:588–91.
  • Dusak A, Onur MR, Cicek M, Firat U, Ren T, Dogra VS. Radiological imaging features of Fasciola hepatica infection—a pictorial review. J Clin Imaging Sci 2012;2:2.
  • Lopez M, White AC, Jr, Cabada MM. Burden of Fasciola hepatica infection among children from Paucartambo in Cusco, Peru. Am J Trop Med Hyg 2012;86:481–5.
  • Fürst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:210–21.
  • Keiser J, Duthaler U, Utzinger J. Update on the diagnosis and treatment of food-borne trematode infections. Curr Opin Infect Dis 2010;23:513–20.
  • Fried B, Abruzzi A. Food-borne trematode infections of humans in the United States of America. Parasitol Res 2010;106:1263–80.
  • Keiser J, Utzinger J. Food-borne trematodiases. Clin Microbiol Rev 2009;22:466–83.
  • Le TH, De NV, Agatsuma T, Blair D, Vercruysse J, Dorny P, Nguyen TG, McManus DP. Molecular confirmation that Fasciola gigantica can undertake aberrant migrations in human hosts. J Clin Microbiol 2007;45:648–50.
  • Boyce WM, Courtney CH. Seasonal transmission of Fasciola hepatica in north central Florida (U.S.A.). Int J Parasitol 1990;20:695–6.
  • Hauser SC, Bynum TE. Abnormalities on ERCP in a case of human fascioliasis. Gastrointest Endosc 1984;30:80–2.
  • Norton RA, Monroe L. Infection by Fasciola hepatica acquired in California. Gastroenterol 1961;41:46–8.

Back to Top

Page last reviewed: January 14, 2019